The present invention provides a labelled compound suitable for use as an in vivo imaging agent. The in vivo imaging agent of the invention is useful in the in vivo diagnosis and imaging of fibrosis and in particular fibrosis in the liver. Also provided by the present invention is a method for the preparation of the labelled compound of the invention and a precursor compound useful in said method and a kit useful for carrying out said method. In addition, the present invention provides a pharmaceutical composition comprising the labelled compound of the invention as well as a method of in vivo imaging using the labelled compound of the invention, preferably as the pharmaceutical composition of the invention.
申请公布号
WO2014001538(A1)
申请公布日期
2014.01.03
申请号
WO2013EP63702
申请日期
2013.06.28
申请人
GE HEALTHCARE LIMITED
发明人
OLSSON, ANDREAS;ACHANATH, RADHA;IVESON, PETER, BRIAN;TUCH, DAVID